Literature DB >> 3426928

Survival of large bowel carcinoma patients with different DNA ploidy.

T O Rognum1, E Thorud, E Lund.   

Abstract

One hundred patients operated for large bowel carcinoma were divided into a distinct aneuploid group of 63, and a near diploid one of 37. Flow cytometry was used for determination of the DNA ploidy pattern. All tumours in the aneuploid group contained one or more aneuploid cell populations. All patients were followed clinically from 3.5 to 7.8 years. The corrected 5 year survival was 64% and 49% for patients with near diploid and aneuploid tumours, respectively (not significant). Significant differences in corrected survival time were not observed for Dukes' stages A, B, and C patients pooled, nor for Dukes' stage D patients. However, for Dukes' stage C patients alone, there was a tendency (P = 0.10) for patients with near diploid tumours to show a better survival. A highly significant predominance of aneuploid tumours was seen in males, in contrast to an equal distribution of aneuploid and near diploid tumours in females. A slight predominance of aneuploid tumours in the left colon and rectum was seen. Both these findings indicate the influence of environmental factors (hormonal, anatomical, phenotypical) on the development of tumours with a particular DNA ploidy pattern.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426928      PMCID: PMC2001905          DOI: 10.1038/bjc.1987.257

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

Review 2.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

3.  DNA distribution in human colon carcinomas and its relationship to clinical behavior.

Authors:  R C Wolley; K Schreiber; L G Koss; M Karas; A Sherman
Journal:  J Natl Cancer Inst       Date:  1982-07       Impact factor: 13.506

4.  Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus.

Authors:  N B Atkin
Journal:  J Natl Cancer Inst       Date:  1976-05       Impact factor: 13.506

5.  Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas.

Authors:  P Quirke; M F Dixon; A D Clayden; P Durdey; J E Dyson; N S Williams; C C Bird
Journal:  J Pathol       Date:  1987-04       Impact factor: 7.996

Review 6.  Clinical application of flow cytometry: a review.

Authors:  O D Laerum; T Farsund
Journal:  Cytometry       Date:  1981-07

7.  Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry.

Authors:  D J Perez; I W Taylor; B K Milthorpe; V J McGovern; M H Tattersall
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

8.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

9.  Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma.

Authors:  T O Rognum; E Thorud; K Elgjo; P Brandtzaeg; H Orjasaeter; K Nygaard
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

10.  Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas?

Authors:  T O Rognum; P Brandtzaeg; E Thorud
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more
  12 in total

Review 1.  Genetics of colon cancer.

Authors:  D J Ahnen
Journal:  West J Med       Date:  1991-06

2.  Venous invasion as a prognostic factor in colorectal cancer.

Authors:  A Tsuchiya; Y Ando; Y Kikuchi; M Kanazawa; H Sato; R Abe
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Clinical importance of DNA content in rectal cancer measured by flow cytometry.

Authors:  J R Jass; K Mukawa; H S Goh; S B Love; D Capellaro
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

4.  Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

Authors:  G Lindmark; B Glimelius; L Påhlman; P Enblad
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

5.  DNA densitometry of colorectal cancer.

Authors:  G T Deans; K Williamson; P Hamilton; M Heatley; K Arthurs; C C Patterson; B J Rowlands; T G Parks; R A Spence
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

6.  The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.

Authors:  M Kouri; S Pyrhönen; J P Mecklin; H Järvinen; A Laasonen; K Franssila; S Nordling
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

7.  The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis.

Authors:  N C Armitage; K C Ballantyne; D F Evans; P Clarke; J Sheffield; J D Hardcastle
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience.

Authors:  R Silvestrini; I D'Agnano; A Faranda; A Costa; G Zupi; M Cosimelli; V Quagliuolo; D Giannarelli; L Gennari; R Cavaliere
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.

Authors:  G I Meling; R A Lothe; A L Børresen; S Hauge; C Graue; O P Clausen; T O Rognum
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.

Authors:  G I Meling; R A Lothe; A L Børresen; C Graue; S Hauge; O P Clausen; T O Rognum
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.